RICHARD KAY: Open Payments
NPI 1063497063 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 10 payments from 6 companies in 2025. Trend: 2023 $14 · 2024 $101 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $107 |
| Novo Nordisk Inc | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: Korlym, JARDIANCE, ImmunoCAP, Ozempic, TRELEGY ELLIPTA, GEMTESA.
Industry payments across IL — which companies pay providers there.
